Clinical Impact of Del Nido Cardioplegia in Adult Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

474

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

December 15, 2019

Study Completion Date

February 28, 2020

Conditions
Heart; Surgery, Heart, Functional Disturbance as Result
Interventions
DRUG

DEL NIDO CARDIOPLEGIA

"Del Nido components: Plasmalyte 148 (1000 ml), NaHCO3 8.4% 1M (13 ml), MgSO4 0,5 M (16,5 ml), Mannitol 20% (16,3 ml), KCl 2 M (13 ml), Lidocaine 2% (6,5 ml).~Electrolytic composition (l000 ml): Na+ 153 mEq, K+ 31 mEq, Cl - 124 mEq, Mg2+ 19,5 mEq, NaHCO3 13 mEq, Acetate 27 mEq, Sulfate 16,5 mEq, Gluconate 23 mEq."

DRUG

COLD BLOOD BASED CARDIOPLEGIA

Cardibraun components: Electrolytic composition (1000 ml): Na+ 185,8 mmol, K+ 24,1 mmol, Cl- 192,8 mmol, Acetate 23 mmol, Fosfate 0,97 mmol, Citrate 6,32 mmol.

Trial Locations (1)

28222

Puerta de Hierro Hospital, Majadahonda

All Listed Sponsors
lead

JESSICA GARCIA SUAREZ

OTHER

NCT04094168 - Clinical Impact of Del Nido Cardioplegia in Adult Cardiac Surgery | Biotech Hunter | Biotech Hunter